Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways
Stefania Livia Ciummo, Carlo Sorrentino, Cristiano Fieni, Emma Di Carlo · 2023
Read Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways by Stefania Livia Ciummo, Carlo Sorrentino, Cristiano Fieni, Emma Di Carlo (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714661.txt.
Description
A signal protein made by prostate cancer cells warps the blood vessels that feed the tumor. Stefania Ciummo, Carlo Sorrentino, Cristiano Fieni, and Emma Di Carlo grew cancer and vessel cells together in 2023 to watch the cross-talk. Touch with cancer cells made vessel cells grow and pour out vessel-building goods. When the cancer made the signal, called IL-30, the flood grew stronger and fed loops that fed themselves.
Cutting the signal's gene out of the cancer starved the vessel side and shrank tumor blood growth in tests. The talk also ran backward: vessel cells in the signal's grip pushed the cancer to switch on immune-shaping and growth genes. Checks in patient samples backed the lab tale. The team name the signal a hub where cancer and vessels conspire.
Catalog record
| CREATOR | Stefania Livia Ciummo, Carlo Sorrentino, Cristiano Fieni, Emma Di Carlo |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |